TY - JOUR
T1 - A continuous model of Angiogenesis
T2 - Initiation, extension, and maturation of new blood vessels modulated by vascular endothelial growth factor, Angiopoietins, platelet-derived growth factor-B, and pericytes
AU - Zheng, Xiaoming
AU - Koh, Gou Young
AU - Jackson, Trachette
PY - 2013/6
Y1 - 2013/6
N2 - This work presents a continuous model for three early stage events in angiogenesis: initiation, sprout extension, and vessel maturation. We carefully examine the regulating mechanisms of vascular endothelial growth factor (VEGF) and angiopoietins (Ang1 and Ang2) on the proliferation, migration and maturation of endothelial cells through their endothelium-specific receptor tyrosine kinase VEGFR2 and Tie2, respectively. We also consider the effect of platelet-derived growth factor-B (PDGF-B) on the proliferation and migration of pericytes. For growth factors, we present a mathematical model integrating molecular reactions on blood vessels with tissue-level diffusion. For capillary extension, we develop a visco-elastic model to couple tip cell protrusion, endothelium elasticity, and stalk cell proliferation. Our model reproduces corneal angiogenesis experiments and several anti-angiogenesis therapy results. This model also demonstrates that (1) the competition between Ang1 and Ang2 is the angiogenic switch; (2) the maturation process modulated by pericytes and angiopoietins is crucial to vessel normalization and can explain the resistance to anti-VEGF therapy; (3) combined anti-pericyte and anti-VEGF therapy enhances blood vessel regression over anti-VEGF therapy alone.
AB - This work presents a continuous model for three early stage events in angiogenesis: initiation, sprout extension, and vessel maturation. We carefully examine the regulating mechanisms of vascular endothelial growth factor (VEGF) and angiopoietins (Ang1 and Ang2) on the proliferation, migration and maturation of endothelial cells through their endothelium-specific receptor tyrosine kinase VEGFR2 and Tie2, respectively. We also consider the effect of platelet-derived growth factor-B (PDGF-B) on the proliferation and migration of pericytes. For growth factors, we present a mathematical model integrating molecular reactions on blood vessels with tissue-level diffusion. For capillary extension, we develop a visco-elastic model to couple tip cell protrusion, endothelium elasticity, and stalk cell proliferation. Our model reproduces corneal angiogenesis experiments and several anti-angiogenesis therapy results. This model also demonstrates that (1) the competition between Ang1 and Ang2 is the angiogenic switch; (2) the maturation process modulated by pericytes and angiopoietins is crucial to vessel normalization and can explain the resistance to anti-VEGF therapy; (3) combined anti-pericyte and anti-VEGF therapy enhances blood vessel regression over anti-VEGF therapy alone.
KW - Angiogenesis
KW - Angiopoietin-1
KW - Angiopoietin-2
KW - Antiangiogenic therapy
KW - Corneal angiogenesis
KW - Endothelial cells
KW - Initiation
KW - Maturation
KW - Migration
KW - Pericytes
KW - Platelet-derived growth factor-B
KW - Tie2
KW - Vascular endothelial growth factor
KW - Viscoelastic model
UR - http://www.scopus.com/inward/record.url?scp=84874736686&partnerID=8YFLogxK
U2 - 10.3934/dcdsb.2013.18.1109
DO - 10.3934/dcdsb.2013.18.1109
M3 - Article
AN - SCOPUS:84874736686
SN - 1531-3492
VL - 18
SP - 1109
EP - 1154
JO - Discrete and Continuous Dynamical Systems - Series B
JF - Discrete and Continuous Dynamical Systems - Series B
IS - 4
ER -